Earnings Per Share, Diluted of CHAMPIONS ONCOLOGY, INC. from 31 Oct 2013 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
CHAMPIONS ONCOLOGY, INC. quarterly and annual Earnings Per Share, Diluted in USD/shares history and change rate from 31 Oct 2013 to 31 Oct 2025.
  • CHAMPIONS ONCOLOGY, INC. Earnings Per Share, Diluted for the quarter ending 31 Oct 2025 was 0.02, a 60% decline year-over-year.
  • CHAMPIONS ONCOLOGY, INC. Earnings Per Share, Diluted for the twelve months ending 31 Oct 2025 was 0.18.
  • CHAMPIONS ONCOLOGY, INC. annual Earnings Per Share, Diluted for 2024 was 0.33.
  • CHAMPIONS ONCOLOGY, INC. annual Earnings Per Share, Diluted for 2023 was -0.54, a 38% decline from 2022.
  • CHAMPIONS ONCOLOGY, INC. annual Earnings Per Share, Diluted for 2022 was -0.39, a 1075% decline from 2021.
Source SEC data
View on sec.gov
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Change (%)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Change (%)

CHAMPIONS ONCOLOGY, INC. Quarterly Earnings Per Share, Diluted (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 0.18 0.02 -0.03 -60% 01 Aug 2025 31 Oct 2025 10-Q 15 Dec 2025 2026 Q2
Q2 2025 0.21 -0.03 -0.12 -133% 01 May 2025 31 Jul 2025 10-Q 15 Sep 2025 2026 Q1
Q1 2025 0.33 -0.12 -0.11 -1100% 01 Feb 2025 30 Apr 2025 10-K 23 Jul 2025 2025 FY
Q4 2024 0.44 0.31 +0.5 01 Nov 2024 31 Jan 2025 10-Q 17 Mar 2025 2025 Q3
Q3 2024 -0.06 0.05 +0.2 01 Aug 2024 31 Oct 2024 10-Q 15 Dec 2025 2026 Q2
Q2 2024 -0.26 0.09 +0.28 01 May 2024 31 Jul 2024 10-Q 15 Sep 2025 2026 Q1
Q1 2024 -0.54 -0.01 +0.18 +95% 01 Feb 2024 30 Apr 2024 10-K 23 Jul 2025 2025 FY
Q4 2023 -0.72 -0.19 -0.01 -5.6% 01 Nov 2023 31 Jan 2024 10-Q 17 Mar 2025 2025 Q3
Q3 2023 -0.71 -0.15 -0.15 01 Aug 2023 31 Oct 2023 10-Q 16 Dec 2024 2025 Q2
Q2 2023 -0.56 -0.19 -0.17 -850% 01 May 2023 31 Jul 2023 10-Q 13 Sep 2024 2025 Q1
Q1 2023 -0.39 -0.19 -0.17 -850% 01 Feb 2023 30 Apr 2023 10-K 19 Jul 2024 2024 FY
Q4 2022 -0.22 -0.18 -0.23 -460% 01 Nov 2022 31 Jan 2023 10-Q 15 Mar 2024 2024 Q3
Q3 2022 0.01 0 -0.02 -100% 01 Aug 2022 31 Oct 2022 10-Q 13 Dec 2023 2024 Q2
Q2 2022 0.03 -0.02 -0.01 -100% 01 May 2022 31 Jul 2022 10-Q 13 Sep 2023 2024 Q1
Q1 2022 0.04 -0.02 +0.04 +67% 01 Feb 2022 30 Apr 2022 10-K 24 Jul 2023 2023 FY
Q4 2021 0 0.05 -0.02 -29% 01 Nov 2021 31 Jan 2022 10-Q 16 Mar 2023 2023 Q3
Q3 2021 0.02 0.02 +0.02 01 Aug 2021 31 Oct 2021 10-Q 13 Dec 2022 2023 Q2
Q2 2021 0 -0.01 -0.02 -200% 01 May 2021 31 Jul 2021 10-Q 12 Sep 2022 2023 Q1
Q1 2021 0.02 -0.06 +0.11 +65% 01 Feb 2021 30 Apr 2021 10-K 22 Jul 2022 2022 FY
Q4 2020 -0.09 0.07 +0.04 +133% 01 Nov 2020 31 Jan 2021 10-Q 15 Mar 2022 2022 Q3
Q3 2020 -0.13 0 -0.02 -100% 01 Aug 2020 31 Oct 2020 10-Q 13 Dec 2021 2022 Q2
Q2 2020 -0.11 0.01 +0.07 01 May 2020 31 Jul 2020 10-Q 13 Sep 2021 2022 Q1
Q1 2020 -0.18 -0.17 -0.15 -750% 01 Feb 2020 30 Apr 2020 10-K 26 Jul 2021 2021 FY
Q4 2019 -0.03 0.03 +0.06 01 Nov 2019 31 Jan 2020 10-Q 15 Mar 2021 2021 Q3
Q3 2019 -0.09 0.02 0 0% 01 Aug 2019 31 Oct 2019 10-Q 14 Dec 2020 2021 Q2
Q2 2019 -0.09 -0.06 -0.1 -250% 01 May 2019 31 Jul 2019 10-Q 14 Sep 2020 2021 Q1
Q1 2019 0.01 -0.02 +0.03 +60% 01 Feb 2019 30 Apr 2019 10-K 28 Jul 2020 2020 FY
Q4 2018 -0.02 -0.03 -0.02 -200% 01 Nov 2018 31 Jan 2019 10-Q 16 Mar 2020 2020 Q3
Q3 2018 0 0.02 +0.03 01 Aug 2018 31 Oct 2018 10-Q 16 Dec 2019 2020 Q2
Q2 2018 -0.03 0.04 +0.1 01 May 2018 31 Jul 2018 10-Q 16 Sep 2019 2020 Q1
Q1 2018 -0.13 -0.05 01 Feb 2018 30 Apr 2018 10-K 29 Jul 2019 2019 FY
Q4 2017 -0.01 01 Nov 2017 31 Jan 2018 10-Q 18 Mar 2019 2019 Q3
Q3 2017 -0.01 01 Aug 2017 31 Oct 2017 10-Q 17 Dec 2018 2019 Q2
Q2 2017 -0.06 01 May 2017 31 Jul 2017 10-Q 14 Sep 2018 2019 Q1
Q1 2016 -1.2 -0.3 0 0% 01 Feb 2016 30 Apr 2016 10-K 29 Jul 2016 2016 FY
Q4 2015 -1.2 -0.28 +0.33 +54% 01 Nov 2015 31 Jan 2016 10-Q 16 Mar 2016 2016 Q3
Q3 2015 -1.53 -0.29 +0.36 +55% 01 Aug 2015 31 Oct 2015 10-Q 15 Dec 2015 2016 Q2
Q2 2015 -1.89 -0.33 +0.31 +48% 01 May 2015 31 Jul 2015 10-Q 11 Sep 2015 2016 Q1
Q1 2015 -2.2 -0.3 01 Feb 2015 30 Apr 2015 10-K 29 Jul 2016 2016 FY
Q4 2014 -0.61 -0.59 -2950% 01 Nov 2014 31 Jan 2015 10-Q 16 Mar 2016 2016 Q3
Q3 2014 -0.65 -0.62 -2067% 01 Aug 2014 31 Oct 2014 10-Q 15 Dec 2015 2016 Q2
Q2 2014 -0.64 01 May 2014 31 Jul 2014 10-Q 11 Sep 2015 2016 Q1
Q4 2013 -0.02 01 Nov 2013 31 Jan 2014 10-Q 17 Mar 2015 2015 Q3
Q3 2013 -0.03 01 Aug 2013 31 Oct 2013 10-Q 15 Dec 2014 2015 Q2

CHAMPIONS ONCOLOGY, INC. Annual Earnings Per Share, Diluted (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 0.33 +0.87 01 May 2024 30 Apr 2025 10-K 23 Jul 2025 2025 FY
2023 -0.54 -0.15 -38% 01 May 2023 30 Apr 2024 10-K 23 Jul 2025 2025 FY
2022 -0.39 -0.43 -1075% 01 May 2022 30 Apr 2023 10-K 19 Jul 2024 2024 FY
2021 0.04 +0.02 +100% 01 May 2021 30 Apr 2022 10-K 24 Jul 2023 2023 FY
2020 0.02 +0.2 01 May 2020 30 Apr 2021 10-K 22 Jul 2022 2022 FY
2019 -0.18 -0.19 -1900% 01 May 2019 30 Apr 2020 10-K 26 Jul 2021 2021 FY
2018 0.01 +0.14 01 May 2018 30 Apr 2019 10-K 28 Jul 2020 2020 FY
2017 -0.13 01 May 2017 30 Apr 2018 10-K 29 Jul 2019 2019 FY
2015 -1.2 +1 +45% 01 May 2015 30 Apr 2016 10-K 29 Jul 2016 2016 FY
2014 -2.2 -2.09 -1900% 01 May 2014 30 Apr 2015 10-K 29 Jul 2016 2016 FY
2013 -0.11 01 May 2013 30 Apr 2014 10-K 29 Jul 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.